Henoch-Schonlein purpura (HSP), the most common form of childhood vasculitis, usually
runs a benign course, and “most patients are fine even without treatment,” says Norman
Ilowite, MD, chief, Pediatric Rheumatology, The Children’s Hospital at Montefiore (CHAM).
“But HSP is so common that every pediatrician will see a child who won’t do well either in the
short term with GI problems or the long run with the kidneys.”

Four-year-old boy diagnosed with bilateral ankle arthritis, palpable purpura
and peticia secondary to HSP
An estimated 2 to 5 percent of HSP patients have
serious GI or renal complications, and reportedly 5 to
15 percent of all end-stage renal disease in children is
associated with HSP.
An Auto-Inflammatory Multisystem Disorder
Henoch-Schonlein purpura is a reactive disease that
causes inflammation in the skin, joints and kidneys.
It aff ects 15 in 100,000 children each year and occurs
twice as often in boys as in girls. Incidence peaks in
children ages 3 to 10 – 75 percent of all HSP patients
are age 9 or younger – and older children may be at
higher risk for more serious disease complications.
HSP With No "P"
As would be expected with this eponymous disease,
“you can’t make the diagnosis until you see the rash,”
says Dr. Ilowite. Sometimes, however, the disease
presents without purpura. “It can be confusing,” says
Dr. Ilowite, “because you can start with GI or joint
disease and it can be difficult to know what’s causing
those things until the rash develops.” On very rare
occasions, HSP has been diagnosed – through IgA
tissue deposition or GI endoscopy – with no purpura.
Gastrointestinal Involvement in Most HSP Patients
Thee most common complaint with HSP is abdominal
pain, a presenting sign in 80 percent of all patients.
When pain is acute and severe or the patient presents
with bloody stools or vomiting, it is essential that “an
obstructive series be done to rule out a catastrophic
GI event,” says Barry Wershil, MD, chief, Pediatric
Gastroenterology, CHAM.
Gastrointestinal complications associated with HSP
can include bowel edema, intestinal bleeding and – in
1 to 13 percent of cases – intussusception, a condition
that causes the bowel to “fold in on itself,” says
Dr. Wershil. “Ordinarily the bowel would simply
unfold,” he explains, “but HSP’s inflammation creates
a lead point that prevents spontaneous reduction.”
Because HSP-associated intussusception is typically
small bowel to small bowel – rather than the more
common ileo-colonic type – ultrasound of the abdomen
rather than barium enema is the preferred imaging
modality. Dr. Wershil believes that “a high index of
suspicion must be maintained, and the patients must
be carefully followed with serial examinations of the
abdomen.”
An estimated 2 to 5 percent of HSP patients have
serious GI or renal complications, and reportedly
5 to 15 percent of all end-stage renal disease in
children is associated with HSP.
Steroid Therapy May Mask Potential Disaster
Experienced care is critical for HSP with abdominal
complaints. Steroids are sometimes used to treat GI
symptoms in HSP, but Dr. Wershil strongly urges that
this therapeutic decision be made by an experienced
gastroenterologist because steroidal immunosuppressants
can “mask an evolving intra-abdominal disaster,”
he says. An undiagnosed intussusception can lead to
perforation and peritonitis.
Severe HSP: Lifelong Renal Problems?
The kidneys are HSP’s second most frequently targeted
system: Half of all children with HSP will have renal
involvement, and 10 percent will develop serious kidney
complications. “All patients who present with purpura
should have their urine checked,” says Frederick Kaskel,
MD, chief, Pediatric Nephrology, CHAM. While mild
proteinuria is common, “persistent proteinuria is a
poor prognosticator,” says Dr. Kaskel. Patients with
hematuria and persistent proteinuria reportedly have
a 15 percent chance of developing renal failure.
Kidney complications don’t always show up right away.
“You may not have renal involvement at the time of the
rash,” says Dr. Kaskel. “It can occur later,” sometimes
months or even years after other symptoms resolve.
A recent study showed that 35 percent of pediatric
patients with severe HSP and glomerulonephritis
developed kidney problems as adults.
Highly Experienced Specialty Care Is Crucial
Though life-threatening HSP complications are rare,
when emergencies arise, expert sub-specialty evaluation
is vital. At CHAM, customized pediatric facilities and
proximate care from the metro area’s most experienced
pediatric rheumatologists, nephrologists and
gastroenterologists
give young HSP patients a distinct
advantage. Because “for this particular disease, says
Dr. Wershil, “what to see – and what to expect –
is really based on prior experience.”
Back to Table of Contents